Barbara Rocca

535 total citations
21 papers, 310 citations indexed

About

Barbara Rocca is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Barbara Rocca has authored 21 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Barbara Rocca's work include Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Barbara Rocca is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Barbara Rocca collaborates with scholars based in Italy. Barbara Rocca's co-authors include Marilena Caresana, Marina Boni, Paolo Bernasconi, Ilaria Giardini, Paola Maria Cavigliano, Silvia Calatroni, Mario Lazzarino, Rita Zappatore, Catherine Klersy and Carlo Bernasconi and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and British Journal of Haematology.

In The Last Decade

Barbara Rocca

20 papers receiving 298 citations

Peers

Barbara Rocca

HEMAT

GENET

PHEOH

GENET

Marilena Caresana Italy

Michael Heinsch Germany

Paola Maria Cavigliano Italy

Thamer Sliwa Austria

Magda Šišková Czechia

Jörg Chromik Germany

G.W. Dewald United States

V. Parlier Switzerland

Laurence Baranger France

Simone Feurstein United States

Marilena Caresana Italy

Barbara Rocca

276 ×1.0

HEMAT

131 ×1.0

GENET

89 ×1.0

53 ×1.0

PHEOH

48 ×1.0

GENET

Citations per year, relative to Barbara Rocca Barbara Rocca (= 1×) peers Marilena Caresana

Countries citing papers authored by Barbara Rocca

Since Specialization

Citations

This map shows the geographic impact of Barbara Rocca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Rocca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Rocca more than expected).

Fields of papers citing papers by Barbara Rocca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Rocca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Rocca. The network helps show where Barbara Rocca may publish in the future.

Co-authorship network of co-authors of Barbara Rocca

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Rocca. A scholar is included among the top collaborators of Barbara Rocca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Rocca. Barbara Rocca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossi, Marianna, Anna Gallì, Elisa Roncoroni, et al.. (2021). Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage. Frontiers in Oncology. 11. 726637–726637. 4 indexed citations

Zappasodi, Patrizia, Laura Marbello, Erika Borlenghi, et al.. (2018). Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network. Annals of Hematology. 97(11). 2107–2115. 2 indexed citations

Invernizzi, Rosangela, Marina Boni, Rita Zappatore, et al.. (2017). MDS/AML del(11)(q14) Share Common Morphological Features Despite Different Chromosomal Breakpoints. Anticancer Research. 37(2). 645–650. 1 indexed citations

Rocca, Barbara, Catherine Klersy, Rita Zappatore, et al.. (2017). Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia. Leukemia & lymphoma. 59(3). 702–709. 6 indexed citations

Elena, Chiara, Anna Gallì, Antonio Bianchessi, et al.. (2016). Somatic Mutations Are Frequently Detected in Chronic Myeloid Leukemia in Chronic Phase and Do Not Affect Response to Tyrosine-Kinase Inhibitors. Blood. 128(22). 1117–1117. 1 indexed citations

Merante, Serena, Virginia Valeria Ferretti, Chiara Elena, et al.. (2016). ‘Real-life’ study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysis. Hematology. 22(1). 1–8. 6 indexed citations

Boni, Marina, Marianna Rossi, Patrizia Zappasodi, et al.. (2012). Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome. Cancer Genetics. 205(6). 285–294. 4 indexed citations

Bernasconi, Paolo, Catherine Klersy, Barbara Rocca, et al.. (2012). Human Telomerase Reverse Transcriptase (hTERT): A New Potential Prognostic Marker in AML?. Blood. 120(21). 4790–4790.

Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2010). Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution. Annals of Hematology. 89(6). 545–551. 16 indexed citations

10.

Klersy, Catherine, Marina Boni, Paola Maria Cavigliano, et al.. (2007). Has Cytogenetic Evolution Any Prognostic Relevance in Myelodysplastic Syndromes (MDS)? A Study on 153 Patients.. Blood. 110(11). 2460–2460. 1 indexed citations

11.

Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2007). World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. British Journal of Haematology. 137(3). 193–205. 64 indexed citations

12.

Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2007). Prognostic Significance of EVI1 Defects in MDS/AML with 3q21q26 Abnormalities.. Blood. 110(11). 4224–4224. 1 indexed citations

13.

Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2006). Clinical Relevance of Cytogenetics in Myelodysplastic Syndromes. Annals of the New York Academy of Sciences. 1089(1). 395–410. 25 indexed citations

14.

Bernasconi, Paolo, Silvia Calatroni, Ilaria Giardini, et al.. (2005). ABL1 amplification in T-cell acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 162(2). 146–150. 17 indexed citations

15.

Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2005). Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution. Leukemia. 19(8). 1424–1431. 59 indexed citations

16.

Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2004). Molecularly Targeted Therapy in Acute Myeloid Leukemia. Annals of the New York Academy of Sciences. 1028(1). 409–422. 8 indexed citations

17.

Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2003). Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia. 17(11). 2107–2112. 47 indexed citations

18.

Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2002). Molecular Genetics of Acute Myeloid Leukemia. Annals of the New York Academy of Sciences. 963(1). 297–305. 9 indexed citations

19.

Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2002). Long‐term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance. British Journal of Haematology. 118(2). 545–549. 12 indexed citations

20.

Bernasconi, Paolo, Marina Boni, Silvia Calatroni, et al.. (2002). Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia. 16(10). 2078–2083. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact